Document
IPR2017-01101, No. 1002-27 Exhibit - Ex 1002 Declaration Of Cory J Berkland, PhD (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01101, No. 1002-27 Exhibit - Ex 1002 Declaration Of Cory J Berkland, PhD (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01101, No. 1011-10 Exhibit - Ex 1011 Elan Pharma Intl Ltd v Abraxis BioScience, Inc, Judgment and Verdict Form, No 06 438 GMS, Dkt 614 D Del June 16, 2008 (P.T.A.B. Apr. 4, 2017...
Cite Document
IPR2017-01101, No. 1011-10 Exhibit - Ex 1011 Elan Pharma Intl Ltd v Abraxis BioScience, Inc, Judgment and Verdict Form, No 06 438 GMS, Dkt 614 D Del June 16, 2008 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01101, No. 1004-3 Exhibit - Ex 1004 Kadima et al, WO 2000006152, published Feb 10, 2000 Kadima (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01101, No. 1004-3 Exhibit - Ex 1004 Kadima et al, WO 2000006152, published Feb 10, 2000 Kadima (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01101, No. 1019-18 Exhibit - Ex 1019 US Application No 11553,339, Non Final Office Action mailed Apr 28, 2009 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01101, No. 1019-18 Exhibit - Ex 1019 US Application No 11553,339, Non Final Office Action mailed Apr 28, 2009 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01101, No. 1022-21 Exhibit - Ex 1022 US Application No 11553,339, Amendment After Final Action Under 37 CFR 1116 dated Apr 14, 2010 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01101, No. 1022-21 Exhibit - Ex 1022 US Application No 11553,339, Amendment After Final Action Under 37 CFR 1116 dated Apr 14, 2010 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01101, No. 1006-5 Exhibit - Ex 1006 Desai et al, WO 1999000113, published Jan 7, 1999 Desai (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01101, No. 1006-5 Exhibit - Ex 1006 Desai et al, WO 1999000113, published Jan 7, 1999 Desai (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01101, No. 1010-9 Exhibit - Ex 1010 EMEA Guidance on Manufacture of the Finished Dosage Form April 1996 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01101, No. 1010-9 Exhibit - Ex 1010 EMEA Guidance on Manufacture of the Finished Dosage Form April 1996 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01101, No. 1023-22 Exhibit - Ex 1023 US Application No 11553,339, Declaration of Neil P Desai Pursuant to 37 CFR 1132 dated Apr 14, 2010 the Inventor Declaration (P.T.A.B. Apr. 4,...
Cite Document
IPR2017-01101, No. 1023-22 Exhibit - Ex 1023 US Application No 11553,339, Declaration of Neil P Desai Pursuant to 37 CFR 1132 dated Apr 14, 2010 the Inventor Declaration (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01101, No. 1008-26 Exhibit - Ex 1008 Physicians Desk Reference 309, 881 887 54th ed 2000 Taxolpaclitaxel Injection Taxol label (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01101, No. 1008-26 Exhibit - Ex 1008 Physicians Desk Reference 309, 881 887 54th ed 2000 Taxolpaclitaxel Injection Taxol label (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01101, No. 1012-11 Exhibit - Ex 1012 Elan Pharma Intl Ltd v Abraxis BioScience, Inc, Sixth Day of Trial, No 06 438 GMS, Dkt 624 D Del June 9, 2008 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01101, No. 1012-11 Exhibit - Ex 1012 Elan Pharma Intl Ltd v Abraxis BioScience, Inc, Sixth Day of Trial, No 06 438 GMS, Dkt 624 D Del June 9, 2008 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01101, No. 1007-6 Exhibit - Ex 1007 Li et al, Fluorescein Binding to Normal Human Serum Proteins Demonstrated by Equilibrium Dialysis, Arch Ophalmol vol 100, 484 87 March 1982 (P...
Cite Document
IPR2017-01101, No. 1007-6 Exhibit - Ex 1007 Li et al, Fluorescein Binding to Normal Human Serum Proteins Demonstrated by Equilibrium Dialysis, Arch Ophalmol vol 100, 484 87 March 1982 (P.T.A.B. Apr.
+ More Snippets
Document
IPR2017-01101, No. 1013-12 Exhibit - Ex 1013 Elan Pharma Intl Ltd v Abraxis BioScience, Inc, Seventh Day of Trial, No 06 438 GMS, Dkt 625 D Del June 10, 2008 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01101, No. 1013-12 Exhibit - Ex 1013 Elan Pharma Intl Ltd v Abraxis BioScience, Inc, Seventh Day of Trial, No 06 438 GMS, Dkt 625 D Del June 10, 2008 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01101, No. 1017-16 Exhibit - Ex 1017 Damascelli, B et al Intraarterial chemotherapy with polyoxyethylated castor oil free paclitaxel, incorporated in albumin nanoparticles ABI 007, Can...
Cite Document
IPR2017-01101, No. 1017-16 Exhibit - Ex 1017 Damascelli, B et al Intraarterial chemotherapy with polyoxyethylated castor oil free paclitaxel, incorporated in albumin nanoparticles ABI 007, Cancer 20
+ More Snippets
Document
IPR2017-01101, No. 1020-19 Exhibit - Ex 1020 US Application No 11553,339, Amendment in Response to Non Final Office Action dated Oct 27, 2009 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01101, No. 1020-19 Exhibit - Ex 1020 US Application No 11553,339, Amendment in Response to Non Final Office Action dated Oct 27, 2009 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01101, No. 1024-23 Exhibit - Ex 1024 US Application No 11553,339, Notice of Allowance and Fees Due mailed June 1, 2010 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01101, No. 1024-23 Exhibit - Ex 1024 US Application No 11553,339, Notice of Allowance and Fees Due mailed June 1, 2010 (P.T.A.B. Apr. 4, 2017)
+ More Snippets